Tianshui Zhongxing Bio-technology Co.,Ltd.

Equities

002772

CNE1000020B6

Fishing & Farming

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
6.93 CNY -3.75% Intraday chart for Tianshui Zhongxing Bio-technology Co.,Ltd. +0.73% -12.17%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Tianshui Zhongxing Bio-technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Tianshui Zhongxing Bio-technology Co.,Ltd. Announces Profit Distribution Proposal for 2023 CI
Tianshui Zhongxing Bio-technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Tianshui Zhongxing Bio-technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Tianshui Zhongxing Bio-technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Tianshui Zhongxing Bio-Technology Co.,Ltd. Approves Final Cash Dividend for A Shares for the Year 2022, Payable on 09 May 2023 CI
Tianshui Zhongxing Bio-Technology Co.,Ltd. Announces Cash Dividend for the Year 2022 CI
Tianshui Zhongxing Bio-technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Tianshui Zhongxing Bio-Technology Co.,Ltd. Proposes Final Dividend for the Year 2022 CI
Tianshui Zhongxing Bio-technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Tianshui Zhongxing Bio-technology’s Profit Seen Tripling in 2022 MT
Zhongxing Bio-technology to Pay Interest on 920 Million Yuan Convertible Bond MT
Zhongxing Bio-technology Unit Halts Production on COVID-19 Outbreak MT
Tianshui Zhongxing Bio-technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Tianshui Zhongxing Bio-technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Tianshui Zhongxing Bio-Technology Co.,Ltd. Announces 2021 Final Profit Distribution Plan, Payable on 19 May 2022 CI
Tianshui Zhongxing Bio-technology Co.,Ltd. Approves Cash Dividend for 2021 CI
Tianshui Zhongxing Bio-technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Tianshui Zhongxing Bio-technology Keeps Final Dividend Unchanged Despite 71% Profit Slump in 2021 MT
Tianshui Zhongxing Bio-Technology Co.,Ltd. Proposes Final Dividend for the Year 2021 CI
Tianshui Zhongxing Bio-technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Tianshui Zhongxing Bio-technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Tianshui Zhongxing Bio-Technology Scraps Plan to Buy Wine Company CI
Tianshui Zhongxing Bio-technology Co.,Ltd. cancelled the acquisition of Guizhou Moutai Shengjiao Wine Industry Co., Ltd. from Liu Liangyue and Liu Jian. CI
Tianshui Zhongxing Bio-Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Chart Tianshui Zhongxing Bio-technology Co.,Ltd.
More charts
Tianshui Zhongxing Bio-technology Co., Ltd. is principally engaged in the research and development, production and sale of edible mushroom. The Company's edible mushroom products include enoki mushroom, king oyster mushroom and beech mushroom. Through its subsidiaries, the Company also involves in the production and sale of edible mushroom, medicinal mushroom and auxiliary materials, research and development, application and promotion of microbial technology, biological engineering technology and new agricultural technologies, as well as the manufacture, process and distribution of agricultural by-products.
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 002772 Stock
  4. News Tianshui Zhongxing Bio-technology Co.,Ltd.
  5. Zhongxing Bio-technology Unit Halts Production on COVID-19 Outbreak